Last reviewed · How we verify
Anesthetic blockades with bupivacaine
Anesthetic blockades with bupivacaine is a Local anesthetic Small molecule drug developed by César Fernández-de-las-Peñas. It is currently in Phase 2 development for Postoperative pain management, Pain management during labor and delivery.
Bupivacaine works by blocking sodium channels in nerve fibers, preventing the initiation and transmission of nerve impulses.
Bupivacaine works by blocking sodium channels in nerve fibers, preventing the initiation and transmission of nerve impulses. Used for Postoperative pain management, Pain management during labor and delivery.
At a glance
| Generic name | Anesthetic blockades with bupivacaine |
|---|---|
| Sponsor | César Fernández-de-las-Peñas |
| Drug class | Local anesthetic |
| Target | Voltage-gated sodium channels |
| Modality | Small molecule |
| Therapeutic area | Pain management |
| Phase | Phase 2 |
Mechanism of action
This blockade of sodium channels results in a loss of motor and sensory function in the affected area, providing effective pain relief. Bupivacaine's mechanism of action is reversible, and its effects can be reversed with the administration of a local anesthetic reversal agent.
Approved indications
- Postoperative pain management
- Pain management during labor and delivery
Common side effects
- Central nervous system toxicity
- Cardiovascular toxicity
- Nerve damage
Key clinical trials
- Determination of Minimum Effective Volume of Local Anesthetic in Patients Undergoing Ultrasound-Guided Infraclavicular Approach for Brachial Plexus Blockade (PHASE4)
- Anesthetic Blockades and Migraine (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Anesthetic blockades with bupivacaine CI brief — competitive landscape report
- Anesthetic blockades with bupivacaine updates RSS · CI watch RSS
- César Fernández-de-las-Peñas portfolio CI
Frequently asked questions about Anesthetic blockades with bupivacaine
What is Anesthetic blockades with bupivacaine?
How does Anesthetic blockades with bupivacaine work?
What is Anesthetic blockades with bupivacaine used for?
Who makes Anesthetic blockades with bupivacaine?
What drug class is Anesthetic blockades with bupivacaine in?
What development phase is Anesthetic blockades with bupivacaine in?
What are the side effects of Anesthetic blockades with bupivacaine?
What does Anesthetic blockades with bupivacaine target?
Related
- Drug class: All Local anesthetic drugs
- Target: All drugs targeting Voltage-gated sodium channels
- Manufacturer: César Fernández-de-las-Peñas — full pipeline
- Therapeutic area: All drugs in Pain management
- Indication: Drugs for Postoperative pain management
- Indication: Drugs for Pain management during labor and delivery
- Compare: Anesthetic blockades with bupivacaine vs similar drugs
- Pricing: Anesthetic blockades with bupivacaine cost, discount & access